nasal type extranodal NK/T-cell lymphoma (Cancer)
Information
- Disease name
- nasal type extranodal NK/T-cell lymphoma
- Disease ID
- DOID:0080797
- Description
- "A mature T-cell and NK-cell lymphoma that is characterized by an often angiocentric and angiodestructive cellular infiltrate composed of EBV positive NK/T cells." [url:https\://pubmed.ncbi.nlm.nih.gov/29602763/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02652715 | Completed | N/A | Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma | January 19, 2016 | November 12, 2019 |
| NCT02825147 | Completed | Phase 2 | Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma | September 2013 | July 2017 |
| NCT01787409 | Recruiting | N/A | Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency | March 6, 2013 | March 28, 2025 |
| NCT04096690 | Unknown status | Phase 2 | Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma | September 10, 2019 | December 2022 |
- Disase is a (Disease Ontology)
- DOID:0050743
- Cross Reference ID (Disease Ontology)
- ICDO:9719/3
- Cross Reference ID (Disease Ontology)
- NCI:C4684